{"id":1537,"date":"2016-12-07T16:57:16","date_gmt":"2016-12-07T21:57:16","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1537"},"modified":"2016-12-07T16:57:16","modified_gmt":"2016-12-07T21:57:16","slug":"secondaries-announced-1272016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1272016\/","title":{"rendered":"Secondaries announced 12\/7\/2016"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n

Company:\tClearside Biomedical, Inc.
\nSymbol:\tCLSD
\nPrice:\t\tLast trade $14.43
\nTrade Date:\t12\/9
\nShares:\t5.2 million
\nUnderwriter(s)J.P. Morgan, Cowen, Stifel
\nCoManager(s)Wedbush PacGrow
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tJernigan Capital, Inc.
\nSymbol:\tJCAP
\nPrice:\t\tLast trade $20.21
\nDescription:\tRe-offer $18.75-$19.25
\nTrade Date:\t12\/8
\nShares:\t2.5 million
\nUnderwriter(s)Raymond James, Jefferies
\nCoManager(s)Baird, FBR
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tCompass Diversified Holdings
\nSymbol:\tCODI
\nPrice:\t\tLast trade $19.30
\nDescription:\tRe-offer $18.65
\nTrade Date:\t12\/8
\nShares:\t5.6 million
\nUnderwriter(s)BofA Merrill Lynch, UBS, Jefferies, Raymond James
\nCo Manager(s)Janney Montgomery Scott, William Blair, CJS Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tOhr Pharmaceutical, Inc.
\nSymbol:\tOHRP
\nPrice:\t\tLast trade $2.50
\nTrade Date:\tTBD
\nShares:\tTBD
\nUnderwriter(s)H.C. Wainwright
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tThe Williams Companies, Inc.
\nSymbol:\tWMB
\nPrice:\t\tLast trade $31.60
\nDescription:\tRe-offer range $31.30-$31.60
\nTrade Date:\t12\/8
\nShares:\t13 million
\nUnderwriter(s)Barclays
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tEagle Point Credit Company
\nSymbol:\tECC
\nPrice:\t\tLast trade $18.00
\nDescription:\tRe-offer $17.52
\nTrade Date:\t12\/8
\nShares:\t1.15 million
\nUnderwriter(s)Keefe, Bruyette & Woods, Ladenburg Thalmann, Wunderlich
\nCo Manager(s)FBR Capital Markets, MUFG Securities Americas, National Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company:\tMCBC Holdings Inc.
\nSymbol:\tMCFT
\nPrice:\t\tLast trade $14.18
\nDescription:\tNo re-offer range available
\nTrade Date:\t12\/8
\nShares:\t1 million
\nUnderwriter(s)B. Riley
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Clearside Biomedical, Inc. Symbol: CLSD Price: Last trade $14.43 Trade Date: 12\/9 Shares: 5.2 million Underwriter(s)J.P. Morgan, Cowen, Stifel CoManager(s)Wedbush PacGrow[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[957,958,960,249,527,101,959],"class_list":["post-1537","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-clsd","tag-codi","tag-eec","tag-jcap","tag-mcft","tag-ohrp","tag-wmb"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1537"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1537\/revisions"}],"predecessor-version":[{"id":1538,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1537\/revisions\/1538"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}